Bala Mohan
- SEC CIK
- 0001991787
In the past year, 1 open-market sale filing worth $762.3 and no purchases.
Current role at each company
- MRSN Mersana Therapeutics, Inc.SVP, Chief Developmentas of Jan 6, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $762.3
- 1 filing
- Net
- −$762.3
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Bala Mohan as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 28, 2025 (view filing) | Oct 27 | 1 day | Bala MohanSVP, Chief Development Officer | SSale | −77 | $9.90 | −$762.3 | −2.6%2.92K after | 10b5-1 |
| Jan 17, 2025 (view filing) | Jan 16 | 1 day | Bala MohanSVP, Chief Development Officer | SSale | −5.94K | $0.58 | −$3.44K | −7.9%68.9K after | 10b5-1 |
| Jan 15, 2025 (view filing) | Jan 14 | 1 day | Bala MohanSVP, Chief Development Officer | SSale | −3.25K | $0.66 | −$2.15K | −5.1%60.2K after | 10b5-1 |
| Oct 29, 2024 (view filing) | Oct 28 | 1 day | Bala MohanSVP, Chief Development Officer | SSale | −1.88K | $1.90 | −$3.58K | −3.3%54.7K after | 10b5-1 |
| Oct 7, 2024 (view filing) | Oct 2-3 | 5 daysLate | Bala MohanSVP, Chief Development Officer | SSale | −13.7K | $1.98 | −$27.2K | −21.4%50.4K after | 2 lots10b5-1 |
| Jan 17, 2024 (view filing) | Jan 16 | 1 day | Bala MohanSVP, Chief Development Officer | SSale | −3.43K | $2.71 | −$9.30K | −19.6%14.1K after | 10b5-1 |
| Oct 27, 2023 (view filing) | Oct 26 | 1 day | Bala MohanSVP, Chief Development Officer | SSale | −1.91K | $1.13 | −$2.16K | −18.0%8.73K after | 10b5-1 |